These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 80341)

  • 1. Immunosuppressive factors in serum of patients with gastric carcinoma.
    Urushizaki I; Ishitani K; Nagai T; Gocho Y; Koyama R
    Gan; 1977 Aug; 68(4):413-21. PubMed ID: 80341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on an inhibitory factor to phytohemagglutinin-induced lymphocyte transformation found in the serum of patients with various liver diseases.
    Nakao M; Mizoguchi Y; Monna T; Yamamoto S; Morisawa S
    Acta Hepatogastroenterol (Stuttg); 1978 Oct; 25(5):335-43. PubMed ID: 83090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive activity of sera from gastric cancer patients.
    Sakita M; Torii T; Imaki S; Kasuga M; Tamai M; Suzuki G; Kano M; Fujita Y; Majima S
    Jpn J Surg; 1984 Mar; 14(2):127-34. PubMed ID: 6431162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of globulin fractions in patients with gastric carcinoma using the Ouchterlony test.
    Adamczyk B; Kulpa J
    Pol Med J; 1968; 7(1):139-45. PubMed ID: 4172090
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance of human Tr cell in gastric cancer --with special reference to suppressor cell activity].
    Itagaki E; Toge T; Tanada M; Hamamoto S; Seto Y; Kohno H; Hattori T
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):123-9. PubMed ID: 6230053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of alpha1-antitrypsin and alpha2-macroglobulin in lung cancer.
    Micksche M; Kokron O
    Osterr Z Onkol; 1977; 3(5-6):116-9. PubMed ID: 67586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the nonspecific cellular immune response in patients with urinary bladder carcinoma. II. Immunodepressive effect of sera from bladder carcinoma.
    Nishio S; Horii A; Morikawa Y; Kawakita J; Nishijima T; Kishimoto T; Maekawa M
    Invest Urol; 1979 Mar; 16(5):342-5. PubMed ID: 429128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-2-macroglobulin deficiency in patients with advanced prostate cancer.
    Ohtani H; Saito M; Koshiba K
    Oncology; 1985; 42(6):341-4. PubMed ID: 2415892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The relationship between serum immunosuppressive acidic protein (IAP) and cellular immunity in the patients with gastric cancer].
    Nakanishi K; Toge T; Hamamoto S; Tanada M; Itagaki E; Kohno H; Yanagawa E; Hattori T
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1827-31. PubMed ID: 6223588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of impaired activation of lymphocytes by suppressive factor in Crohn's disease patients.
    Watanabe M; Tsuru S; Aiso S; Hibi T; Yoshida T; Asakura H; Zinnaka Y; Tsuchiya M
    J Clin Lab Immunol; 1984 May; 14(1):29-34. PubMed ID: 6748044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-dependent changes in inhibitory effect of human sera on phytohemagglutinin (PHA)-stimulated lymphocyte proliferation: its relationship to serum alpha 2-macroglobulin.
    Oshida Y; Hiratani M; Muto K; Ito S; Kasei M
    Arerugi; 1985 Jan; 34(1):62-9. PubMed ID: 2581529
    [No Abstract]   [Full Text] [Related]  

  • 12. [Characteristics of the carbohydrate structure of alpha 2-macroglobulin in stomach cancer].
    Smorodin EP; Kurtenkov OA
    Eksp Onkol; 1986; 8(2):42-5. PubMed ID: 2421999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunological significance of splenectomy in gastric cancer surgery. Production of immunosuppressive factor in the spleen].
    Kanayama H; Oda M; Karino T; Yamane T; Hamazoe R; Osaki Y; Shimizu N; Maeta M; Koga S
    Nihon Geka Gakkai Zasshi; 1983 Sep; 84(9):952-6. PubMed ID: 6676666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of gastric cancer cells on lymphocyte proliferation.
    Wu CW; Chiu CC; Lui WY; P'eng FK; Wang SR
    Asian Pac J Allergy Immunol; 1988 Jun; 6(1):29-32. PubMed ID: 3166644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Search for blocking factors in sera of patients with prostatic cancer.
    Menon M; Stefani SS
    J Urol; 1979 Oct; 122(4):503-5. PubMed ID: 90178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sera of patients with genitourinary tract cancers on transformation of lymphocytes stimulated with anti-thymocyte globulin.
    Prager MD; Gregg DE; Walter MC
    Natl Cancer Inst Monogr; 1978 Dec; (49):127-30. PubMed ID: 311892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary immune response to sheep red blood cells in mice treated with immunoregulatory alpha-globulins (IRA).
    Ptak W; Gumińska M; Stachurska B; Czarnik Z
    Arch Immunol Ther Exp (Warsz); 1976; 24(5):655-8. PubMed ID: 63274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive factor from the spleen in gastric cancer patients.
    Kanayama H; Hamazoe R; Osaki Y; Shimizu N; Maeta M; Koga S
    Cancer; 1985 Oct; 56(8):1963-6. PubMed ID: 3875395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of tumor-specific cell-mediated cytotoxicity by immunoregulatory alpha-globulin and by immunoregulatory alpha-globulin-like peptides from cancer patients.
    Wang BS; Badger AM; Nimberg RR; Cooperband SR; Schmid K; Mannick JA
    Cancer Res; 1977 Sep; 37(9):3022-5. PubMed ID: 69489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppresive effect of a human hepatic glycoferroprotein, alpha2H globulin. A study on the transformation of normal human lymphocytes.
    Buffe D; Rimbaut C
    Immunology; 1975 Jul; 29(1):175-84. PubMed ID: 49295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.